Activity of 2-acetylpyridine and 2 acetylquinoline thiosemicarbazones tested in vitro in combination with other antituberculous drugs

F. M. Collins, D. L. Klayman, N. E. Morrison

Research output: Contribution to journalArticlepeer-review

Abstract

Determinations of minimal inhibitory concentrations (MIC) were carried out using three new 2 acetylpyridine and two new 2-acetylquinoline thiosemicarbazones tested against Mycobacterium tuberculosis, M. kansasii, M. simiae, M. avium, and M. intracellulare. Two of the compounds (Compounds L 31) 30) exhibited MIC ≤ 5 μg per ml for all of the test organisms, except for M. simiae, which was resistant to antituberculous drugs. The other thiosemicarbazones (Compounds 3L, 2N, 3G, and 2H) were relatively inactive against the nontuberculous mycobacteria. Rifampin, amikacin, and clofazimine were active when tested singly or in combination with Compounds L and 31. Addition of compound 31 to a mixture of rifampin, amikacin, and clofazimine resulted in combination MIC of less than 0.6 μg/mg against all of the nontuberculous mycobacteria, suggesting that combinations of this type may be suitable for the treatment of infections caused by these highly drug resistant organisms.

Original languageEnglish (US)
Pages (from-to)58-60
Number of pages3
JournalAmerican Review of Respiratory Disease
Volume125
Issue number1
StatePublished - 1982

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Fingerprint Dive into the research topics of 'Activity of 2-acetylpyridine and 2 acetylquinoline thiosemicarbazones tested in vitro in combination with other antituberculous drugs'. Together they form a unique fingerprint.

Cite this